Structural basis for broad neutralization of HIV-1 through the molecular recognition of 10E8 helical epitope at the membrane interface

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Rujas, Edurne ^a,b   Caaveiro, Jose M M ^b   Partida Hanon, Angélica ^c   Gulzar, Naveed ^d   Morante, Koldo ^b   Apellániz, Beatriz ^a   García Porras, Miguel ^a   Bruix, Marta ^c   Tsumoto, Kouhei ^b   Scott, Jamie K ^d   Jiménez, M Ángeles ^c   Nieva, José L ^a  

^a CSIC UPV Unidad de Biofisica UBF   (Spain)

^b UNIVERSITY OF TOKYO   (Japan)

^c INSTITUTO DE QUÍMICA FÍSICA ROCASOLANO   (Spain)

^d SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 41; GP41 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; NEUTRALIZING ANTIBODY; PEPTIDE;

CHEMISTRY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; PROTEIN SECONDARY STRUCTURE;

ANTIBODIES, NEUTRALIZING; EPITOPES; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV-1; IMMUNOGLOBULIN FAB FRAGMENTS; PEPTIDES; PROTEIN STRUCTURE, SECONDARY;

EID: 85000398924     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38177     Document Type: Article

References (43)

1. Huang, J. et al. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature 491, 406-412 (2012).
2. Kim, A. S., Leaman, D. P. & Zwick, M. B. Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization. PLoS Pathog 10, e1004271 (2014).
3. Soto, C. et al. Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8. PloS One 11, e0157409 (2016).
4. Zwick, M. B. The membrane-proximal external region of HIV-1 gp41: a vaccine target worth exploring. Aids 19, 1725-1737 (2005).
5. Montero, M., van Houten, N. E., Wang, X. & Scott, J. K. The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol Mol Biol Rev 72, 54-84, table of contents (2008).
6. Pegu, A. et al. Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor. Sci Transl Med 6, 243ra288 (2014).
7. van Gils, M. J. & Sanders, R. W. In vivo protection by broadly neutralizing HIV antibodies. Trends Microbiol 22, 550-551 (2014).
8. Barbian, H. J. et al. Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas. mBio 6 (2015).
9. Asokan, M. et al. Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization. J Virol 89, 12501-12512 (2015).
10. Kwon, Y. D. et al. Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design. J Virol 90, 5899-5914 (2016).
11. Kwong, P. D. & Mascola, J. R. Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies. Immunity 37, 412-425 (2012).
12. Burton, D. R. & Mascola, J. R. Antibody responses to envelope glycoproteins in HIV-1 infection. Nat Immunol 16, 571-576 (2015).
13. Apellaniz, B. et al. The Atomic Structure of the HIV-1 gp41 Transmembrane Domain and Its Connection to the Immunogenic Membrane-proximal External Region. J Biol Chem 290, 12999-13015 (2015).
14. Lee, J. H., Ozorowski, G. & Ward, A. B. Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer. Science 351, 1043-1048 (2016).
15. Bird, G. H. et al. Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies. Nat Struct Mol Biol 21, 1058-1067 (2014).
16. Irimia, A., Sarkar, A., Stanfield, R. L. & Wilson, I. A. Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10. Immunity 44, 21-31 (2016).
17. Schibli, D. J., Montelaro, R. C. & Vogel, H. J. The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles. Biochemistry 40, 9570-9578 (2001).
18. Lorizate, M. et al. Recognition and blocking of HIV-1 gp41 pre-transmembrane sequence by monoclonal 4E10 antibody in a Raftlike membrane environment. J Biol Chem 281, 39598-39606 (2006).
19. Huarte, N. et al. The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5. J Virol 82, 8986-8996 (2008).
20. Sun, Z. Y. et al. HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. Immunity 28, 52-63 (2008).
21. Dennison, S. M. et al. Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions. J Virol 83, 10211-10223 (2009).
22. Kim, M. et al. Immunogenicity of membrane-bound HIV-1 gp41 membrane-proximal external region (MPER) segments is dominated by residue accessibility and modulated by stereochemistry. J Biol Chem 288, 31888-31901 (2013).
23. Stanfield, R. L., Zemla, A., Wilson, I. A. & Rupp, B. Antibody elbow angles are influenced by their light chain class. J. Mol. Biol. 357, 1566-1574 (2006).
24. Sun, Z. Y. et al. Disruption of helix-capping residues 671 and 674 reveals a role in HIV-1 entry for a specialized hinge segment of the membrane proximal external region of gp41. J Mol Biol 426, 1095-1108 (2014).
25. Serrano, S. et al. Structure and immunogenicity of a peptide vaccine, including the complete HIV-1 gp41 2F5 epitope: implications for antibody recognition mechanism and immunogen design. J Biol Chem 289, 6565-6580 (2014).
26. Lawrence, M. C. & Colman, P. M. Shape complementarity at protein-protein interfaces. J. Mol. Biol. 234, 946-950 (1993).
27. Young, T. S., Ahmad, I., Yin, J. A. & Schultz, P. G. An enhanced system for unnatural amino acid mutagenesis in E. coli. J Mol Biol 395, 361-374 (2010).
28. Abe, R., Caaveiro, J. M., Kozuka-Hata, H., Oyama, M. & Tsumoto, K. Mapping ultra-weak protein-protein interactions between heme transporters of Staphylococcus aureus. J Biol Chem 287, 16477-16487 (2012).
29. Shepard, L. A. et al. Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: an alpha-helical to beta-sheet transition identified by fluorescence spectroscopy. Biochemistry 37, 14563-14574 (1998).
30. Heuck, A. P., Hotze, E. M., Tweten, R. K. & Johnson, A. E. Mechanism of membrane insertion of a multimeric beta-barrel protein: perfringolysin O creates a pore using ordered and coupled conformational changes. Mol Cell 6, 1233-1242 (2000).
31. Montero, M. et al. Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane. J Virol 86, 2930-2941 (2012).
32. Seaman, M. S. et al. Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J Virol 84, 1439-1452 (2010).
33. White, S. H. & Wimley, W. C. Membrane protein folding and stability: physical principles. Annu Rev Biophys Biomol Struct 28, 319-365 (1999).
34. White, S. H., Ladokhin, A. S., Jayasinghe, S. & Hristova, K. How membranes shape protein structure. J Biol Chem 276, 32395-32398 (2001).
35. Wimley, W. C. & White, S. H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat Struct Biol 3, 842-848 (1996).
36. McDonald, S. K. & Fleming, K. G. Aromatic side chain water-to-lipid transfer free energies show a depth-dependence across the membrane normal. J Am Chem Soc (2016).
37. Dev, J. et al. Structural basis for membrane anchoring of HIV-1 envelope spike. Science 353, 172-175 (2016).
38. Ofek, G. et al. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J Virol 78, 10724-10737 (2004).
39. Song, L. et al. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface. Proc Natl Acad Sci USA 106, 9057-9062 (2009).
40. Cardoso, R. M. et al. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusionassociated motif in gp41. Immunity 22, 163-173 (2005).
41. Ringer, A. L., Senenko, A. & Sherrill, C. D. Models of S/pi interactions in protein structures: comparison of the H2S benzene complex with PDB data. Protein Sci 16, 2216-2223 (2007).
42. Rujas, E. et al. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10. J Virol 89, 11975-11989 (2015).
43. Apellaniz, B. et al. Cholesterol-Dependent Membrane Fusion Induced by the gp41 Membrane-Proximal External Region-Transmembrane Domain Connection Suggests a Mechanism for Broad HIV-1 Neutralization. J Virol 88, 13367-13377 (2014).